Broadview Ventures — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
Adient Medical develops absorbable medical devices, including implants designed to remain safe and effective during their useful lifetime and then dissolve on their own, avoiding removal procedures and related complications.
BiotechHealthtechMedical DevicesPearland, US
Mitchell Eggers(Executive Officer, Director)
BoardMichael Hogan(Director)Robert Tucci(Director)
Co-investorsHouston Angel NetworkTexas HALO FundTexas Ventures
Boston-based developer of an in vitro diagnostic test for diabetes based on the glycated CD59 (GCD59) biomarker.
BiotechBoston, US
Jose Halperin(Director)inJoyce Lonergan(Executive Officer)Michael Chorev(Director)
Co-investorsDreamers VCElephant Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
NIDO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.